TMIQ: Assessing Motor Imagery Ability of Tongue and Mouth in Subjects With and With no Temporomandibular Disorders

Sponsor
Cabinet de Kinesitherapie SCM Saint-Alexandre (Industry)
Overall Status
Completed
CT.gov ID
NCT04102306
Collaborator
University of Lyon (Other), Hospices Civils de Lyon (Other)
94
1
15.1
6.2

Study Details

Study Description

Brief Summary

Temporomandibular disorder (TMD) is the symptomatic expression of a muscular or an articular impairment at the manducatory tract. TMD affects between 30 to 65% of the population with a higher prevalence for young women. The patients with DTM report a decrease of their personal, social and professional quality of life. Treatment usually relies on physical therapy. Among the different technics that can be used in physical therapy, there is growing evidence advocating the efficacy of using motor imagery (i.e. imagining a movement with no concomitant physical execution) during rehabilitation. It has also been shown that the benefits of practicing motor imagery depend on the ability (i.e., the higher the ability, the greater the benefits). However, there is no investigation of the motor imagery ability of the tongue and mouth movements conditioning the use of motor imagery during TMD rehabilitation. The objective of the study is to investigate the ability of imagining tongue and mouth movements using the Tongue and Mouth Imagery Questionnaire (TMIQ) as compare to the gold-standard Kinesthetic and Visual Imagery Questionnaire (KVIQ - Malouin et al., 2007).

Condition or Disease Intervention/Treatment Phase
  • Other: reliability and validity construct of the TMIQ

Detailed Description

Principal objective:

Assess the validity construct of the Tongue and Mouth Imagery Questionnaire (TMIQ) as compare to the gold-standard Kinesthetic and Visual Imagery Questionnaire (KVIQ - Malouin et al., 2007), both measuring the motor imagery vividness.

Secondary objectives:
  1. Assess the reliability of the TMIQ using a test-retest.

  2. Assess the temporal coupling (i.e., the ratio between imagined and physically practiced movement) and compare these ratios for the TMIQ and KVIQ.

  3. Investigate the effect of TMD by comparing the vividness scores of TMIQ for respectively subject with and with no TMD.

  4. Investigate the effect of TMD by comparing the vividness scores of KVIQ for respectively subject with and with no TMD.

  5. Investigate the effect of TMD by comparing the temporal coupling scores of TMIQ for respectively subject with and with no TMD.

  6. Investigate the effect of TMD by comparing the temporal coupling scores of KVIQ for respectively subject with and with no TMD.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
94 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Assessing Motor Imagery Using the Tongue and Mouth Imagery Questionnaire (TMIQ) in Patients With Temporomandibular Disorder and Healthy Control Subjects: a Reliability and Construct Validity Study
Actual Study Start Date :
Sep 26, 2018
Actual Primary Completion Date :
Dec 31, 2019
Actual Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Temporomandibular disorder group (TMD)

Patients with temporomandibular disorder coming at the Cabinet Saint Alexandre for orofacial rehabilitation. Test 1: passation of the KVIQ questionnaire, followed by the passation of the TMIQ during a rehabilitation session supervised by the physical therapist (PT) Test 2: passation of the TMIQ during the next rehabilitation session supervised by the same PT(interval between PT session 1 and 2 is a maximum of 45 days). Questionnaires were performed during the course of the patient rehabilitation that was instructed not to perform imagined movement during the interval.

Other: reliability and validity construct of the TMIQ
comparison of the TMIQ to the gold-standard questionnaire (KVIQ) and test-retest

Control healthy group (CTL)

Healthy individuals with no temporomandibular disorder (i.e., no orofacial medical consultation or rehabilitation) aged-matched and gender-matched to TMD group. Test 1: passation of the KVIQ questionnaire, followed by the passation of the TMIQ during a session supervised by the physical therapist (PT) Test 2: passation of the TMIQ during the next session supervised by the same PT(interval between PT session 1 and 2 is a maximum of 8 days). Questionnaires were performed with no additional rehabilitation and participants were instructed not to perform imagined movement during the interval.

Other: reliability and validity construct of the TMIQ
comparison of the TMIQ to the gold-standard questionnaire (KVIQ) and test-retest

Outcome Measures

Primary Outcome Measures

  1. vividness score of imagined movements of the TMIQ for the DTM group [at study inclusion, i.e day 1]

    Averaged vividness score (using a 5-point likert scale, 1=minimum vividness, 5=maximal vividness) for the TMIQ for the DTM group

  2. vividness score of imagined movements of the TMIQ for the CTL group [at study inclusion, i.e day 1]

    Averaged vividness score (using a 5-point likert scale, 1=minimum vividness, 5=maximal vividness) for the TMIQ for the DTM group

  3. vividness score of imagined movements of the KVIQ for the DTM group [at study inclusion, i.e day 1]

    Averaged vividness score (using a 5-point likert scale, 1=minimum vividness, 5=maximal vividness) for the KVIQ for the DTM group

  4. vividness score of imagined movements of the KVIQ for the CTL group [at study inclusion, i.e day 1]

    Averaged vividness score (using a 5-point likert scale, 1=minimum vividness, 5=maximal vividness) for the KVIQ for the DTM group

Secondary Outcome Measures

  1. vividness score of imagined movements of the TMIQ for the DTM group [at study completion, between 8 days to 45 days after inclusion]

    Averaged vividness score (using a 5-point likert scale, 1=minimum vividness, 5=maximal vividness) for the TMIQ for the DTM group

  2. vividness score of imagined movements of the TMIQ for the CTL group [at study completion, between 8 days to 45 days after inclusion]

    Averaged vividness score (using a 5-point likert scale, 1=minimum vividness, 5=maximal vividness) for the TMIQ for the DTM group

  3. Temporal coupling to imagined movements of the TMIQ for the DTM group [at study completion, between 8 days to 45 days after inclusion]

    Computation of ratio between imagined and physically practiced movements measured during the TMIQ for the DTM group

  4. Temporal coupling to imagined movements of the TMIQ for the CTL group [at study inclusion, i.e day 1]

    Computation of ratio between imagined and physically practiced movements measured during the TMIQ for the DTM group

  5. Temporal coupling to imagined movements of the TMIQ for the CTL group [at study completion, between 8 days to 45 days after inclusion]

    Computation of ratio between imagined and physically practiced movements measured during the TMIQ for the DTM group

Other Outcome Measures

  1. mental representation of the maximal opening of the mouth for the DTM group [at study inclusion, i.e day 1]

    comparison of the score (5-point likert Scale, 1= minimal opening, 5=maximal opening) self-reported by the participant after imagination of maximal mouth opening as compared to the score of the physical therapist after the physical execution of mouth opening by the participant during the TMIQ for the DTM group

  2. mental representation of the maximal opening of the mouth for the CTL group [at study inclusion, i.e day 1]

    comparison of the score (5-point likert Scale, 1= minimal opening, 5=maximal opening) self-reported by the participant after imagination of maximal mouth opening as compared to the score of the physical therapist after the physical execution of mouth opening by the participant during the TMIQ for the CTL group

  3. Accuracy of tongue pointing against the wood examination stick for the DTM group [at study inclusion, i.e day 1]

    Measure the surface of the tongue print after that participant was requested to point as accurately as possible while keeping the tongue sharp against the wood examination stick for the DTM group

  4. Accuracy of tongue pointing against the wood examination stick for the CTL group [at study inclusion, i.e day 1]

    Measure the surface of the tongue print after that participant was requested to point as accurately as possible while keeping the tongue sharp against the wood examination stick for the CTL group

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • age between 18 and 75 years

  • A voluntary individual who has given informed consent after receiving clear, fair and appropriate information about the study.

For DTM group participants

  • inclusion during the DTM rehabilitation in the physical therapy firm "Cabinet Saint Alexandre".

  • beneficiary of the social security scheme

Exclusion Criteria:
  • The presence of a short tongue brake (Marchesan, 2005)

  • Lingual immaturity evaluated by the Tardieu test (Jouannaud et al. 1972)

  • Patients who had orthognathic surgery within 6 months post- operative, or facial fractures according to the same deadlines

  • The presence of peripheral facial palsy

  • Current participation in another research whose objective would be the evaluation of a therapeutic, drug or not, introducing an experimental bias.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cabinet Saint Alexandre Lyon France 69005

Sponsors and Collaborators

  • Cabinet de Kinesitherapie SCM Saint-Alexandre
  • University of Lyon
  • Hospices Civils de Lyon

Investigators

  • Principal Investigator: Caroline Alvarado-Faysse, PT, Cabinet de kinésithérapie Saint Alexandre

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Cabinet de Kinesitherapie SCM Saint-Alexandre
ClinicalTrials.gov Identifier:
NCT04102306
Other Study ID Numbers:
  • TMIQ
First Posted:
Sep 25, 2019
Last Update Posted:
Mar 6, 2020
Last Verified:
Sep 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Cabinet de Kinesitherapie SCM Saint-Alexandre
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 6, 2020